Synthetic Biology – News and Features
News
Invitrogen and Blue Heron Biotechnology Enter into Strategic Development and Distribution Relationship
Invitrogen will invest in Blue Heron in exchange for worldwide rights to distribute Blue Heron's custom gene synthesis services.
News
Glimpse the Future in Synthetic Biology, Cancer and Stem Cells at MASS Opportunities
MASSOpportunities will take place on November 2 at the Hilton Boston Logan Airport, Boston, MA.
News
Sloning Launches with the Production of Synthetic Genes
Company produces synthetic genes using the Slonomics™ technology.
News
CODA Genomics Closes $1.6 Million Series B Financing
Investors believe that CODA’s Translation Engineering™ solves many problems of protein expression.
News
Synthetic Biology Promises to Shape the Future of Life Sciences
Drug applications discovered through synthetic biology have streamlined the pharmaceutical industry’s ability to deliver new therapeutic agents.
Advertisement
